A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients.
Sun C, Guo E, Zhou B, Shan W, Huang J, Weng D, Wu P, Wang C, Wang S, Zhang W, Gao Q, Xu X, Wang B, Hu J, Ma D, Chen G.
Sun C, et al.
BMC Cancer. 2019 Nov 8;19(1):1061. doi: 10.1186/s12885-019-6288-7.
BMC Cancer. 2019.
PMID: 31703584
Free PMC article.